Group leader

Alberto Villanueva

Principal investigators

Enric Condom
David Garcia
Ernest Nadal

PhD students

Nerea Albert
Samuel Gonçalves

Technicians

Griselda Venturas
Maria Martinez
Monica Calaf
Natalia Guillen
Sara Puertas

Scientific production

22
PAPERS
203,484
TOTAL IF
9,690
MEAN IF

17 PUBLICATIONS IN FIRST QUARTILE

10 PUBLICATIONS IN FIRST DECILE

10 ONGOING PROJECTS

1 started in 2016
1 granted in 2016

16 ONGOING CLINICAL TRIALS

8 started in 2016

1 THESIS

1 SPIN-OFF

Highlights

  • Esteller M; Guil S; Diederichs S; Gross M; Villanueva A; Farré L; Martinez-Iniesta M; Akiyama Y; Sala N; Galan M; Paúles M; Vidal A; Espada J; Moutinho C; Heyn H; Gómez A; Martínez-Cardús A; Hashimoto Y; Sandoval J; Goyal A; Setien F; Soler M; Lopez-Serra P; Crujeiras A; Diaz-Lagares A. Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer. Proceedings Of The National Academy Of Sciences Of The United States Of America 2016. DOI: 10.1073/pnas.1608585113
  • Diaz-Lagares, A; Mendez-Gonzalez, J; Hervas, D; Saigi, M; Pajares, MJ; Garcia, D; Crujeiras, AB; Pio, R; Montuenga, LM; Zulueta, J; Nadal, E; Rosell, A; Esteller, M; Sandoval Del Amor, J. A novel epigenetic signature for early diagnosis in lung cancer. Clinical Cancer Research 2016. DOI: 10.1158/1078-0432.CCR-15-2346
  • XENOPAT spin-off